3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Glioblastoma
4
Small Cell Lung Carcinoma
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Gliosarcoma
3
Fallopian Tube Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Astrocytoma
3
Rectal Neoplasms
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Glioma
2
Colorectal Neoplasms
2
Brain Neoplasms
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Sezary Syndrome
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Oropharyngeal Neoplasms
1
Oligodendroglioma
1
Interventions
Cyclophosphamide
18
Trastuzumab
16
Paclitaxel
15
Taxes
11
Doxorubicin
11
Radiotherapy
7
Lapatinib
6
Albumin-Bound Paclitaxel
6
Vorinostat
5
Tamoxifen
5
Docetaxel
5
Carboplatin
5
Capecitabine
5
Bevacizumab
5
Radiation
4
Letrozole
4
Immunohistochemistry
4
Anastrozole
4
sargramostim
3
pegfilgrastim
3
exemestane
3
Magnetic Resonance Spectroscopy
3
Immunoenzyme Techniques
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Granulocyte Colony-Stimulating Factor
3
Fluorodeoxyglucose F18
3
Flow Cytometry
3
Filgrastim
3
Chemotherapy, Adjuvant
3
saponin QA-21V1
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Breast Neoplasms, Male
×
veliparib
×
Clear all
No trials found.